APR 10, 2019 01:30 PM PDT

Laboratory Medicine Beyond The Box: Value Based Health Care & Diagnostic Evidence

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Global Director of Medical Affairs, Microbiology , Roche Molecular Systems
    Biography
      Dr. Elizabeth Marlowe is currently the Global Director of Medical Affairs for Microbiology at Roche Molecular Systems. She received her Ph.D. from the University of Arizona in 1999 and completed a Clinical/Public Health Microbiology Postdoctoral Fellowship in 2001 at the University of California Los Angeles (UCLA) David Geffen School of Medicine. Following her fellowship she continued at UCLA as an Adjunct Professor in the College of Medicine and as a Research Coordinator at the Wadsworth Anaerobe Laboratory at the West Los Angeles VA. In 2002, Dr. Marlowe joined Gen-Probe Incorporated with her primary research in the development of rapid molecular diagnostics for infectious diseases. From 2005 - 2016 she provided laboratory leadership within the Kaiser Permanente Regional Laboratories in both the Southern California region, as the Assistant Director of Microbiology, and the Northern California region, as Technical Director of Microbiology. She is a diplomat of the American Board of Medical Microbiology, past-president for the Southern California American Society for Microbiology and an Editor for the Clinical Microbiology Newsletter. She has served as a member of CLIAC, the federal advisory committee for clinical laboratory improvement amendment (CLIA) to the US Secretary of Health and Human Services. Dr. Marlowe is an elected member to the Council on Microbial Sciences for the American Society for Microbiology. Her research areas of interest are focused on the translation of new infectious disease diagnostics for use in evidence-based research for clinical and public health microbiology practice.
    • Director of Medical Affairs, Point-of-Care, Roche Molecular Systems
      Biography
        Joanna's background spans pharmaceutical, diagnostic and non-governmental organizations with a focus on public health and cost-effectiveness analytics to optimize medical value. As part of the Roche Molecular Diagnostics global medical affairs team she is responsible for developing and executing the point-of-care global medical plan including clinical impact and cost-effectiveness evidence development to support the uptake of new diagnostics. Prior to joining Roche at Zyomyx, she led market access strategy, policy and the post-approval clinical study program to support the launch of the Company's first product, a point-of-care CD4 test for use in limited resource settings. Previously, as part of the Access Programs leadership team at the Clinton Health Access Initiative (CHAI), she developed models and led advocacy for global procurement interventions to ensure the sustainability of the children's HIV drug market. She partnered with Ministries of Health throughout Africa to support the HIV Guidelines revision process and assess the cost impact of changes. She holds Masters in Public Health and Masters in Business Administration degrees from the University of California, Berkeley. She received her Bachelor of Arts degree from Wesleyan University.

      Abstract:

      Dr. Marlowe's presentation will cover: Integration of technology is influencing practice in the clinical laboratory and treatment of patients in the clinical practice arena. As laboratories begin to move from a volume to value model, the mining of big data and its ability to guide clinical decisions through artificial intelligence and machine learning will continue to alter the value assigned to laboratory medicine. These changes and the challenges they pose will be address to investigate the skill set that will be required from this and the next generation of laboratory leaders to successfully leverage the role of the laboratory in a post-technology world.

      Ms. Sickler's presentation will cover: The evidence required to achieve regulatory approval is increasingly not enough to justify adoption of new and often more expensive technologies.  How a test could change clinical care if theoretically utilized in a certain way is no longer compelling to support value.   Clinical evidence must demonstrate in the real world how diagnostic results are integrated into a clinical care continuum and utilized to guide patient care to support value.  



      Learning Objectives: 

      1. Recognize the changing model of laboratory medicine
      2. Define value based care
      3. Discuss the challenges to leveraging laboratory data
      4. Understand the skillset for the next generation laboratorian
      5. Define the different types of diagnostic evidence and common endpoints
      6. Understand the drivers of the shifting evidence landscape


      Show Resources
      You May Also Like
      FEB 26, 2019 09:00 AM PST
      C.E. CREDITS
      FEB 26, 2019 09:00 AM PST
      DATE:  February 26, 2019TIME:   9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
      NOV 15, 2018 10:00 AM PST
      C.E. CREDITS
      NOV 15, 2018 10:00 AM PST
      DATE:  November 15, 2018TIME:  10:00am PT, 1:00pm ET Multiplex fluorescence immunohistochemistry offers a window into the biology of human disease, enabling the ana...
      MAR 26, 2019 02:00 PM PDT
      C.E. CREDITS
      MAR 26, 2019 02:00 PM PDT
      DATE:  March 26, 2019TIME:  2:00pm PDT, 5:00pm EDT  Prostate cancer is the second most common form of cancer in males, affecting one in eight men by the time t...
      NOV 21, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 21, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
      JAN 22, 2019 07:00 AM PST
      C.E. CREDITS
      JAN 22, 2019 07:00 AM PST
      DATE:    January 22, 2019TIME:    07:00am PST, 10:00am EST Molecular diagnostic tests are currently used for infectious disease testing due to t...
      MAY 16, 2019 12:00 PM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 16, 2019 12:00 PM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: May 07, 2019TIME: 10:00 AM PST Mesenchymal stem or stromal cells (MSCs) are a promising resource for cell-based therapies and are being tested in already registered phase...
      Loading Comments...
      Show Resources